Non Hodgkin Lymphoma News and Research

RSS
Recommended amounts of physical activity associated with reduced risk for seven cancers

Recommended amounts of physical activity associated with reduced risk for seven cancers

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

Study: Calcium signaling can help address drug resistance to non-Hodgkin lymphoma

Study: Calcium signaling can help address drug resistance to non-Hodgkin lymphoma

Radiation from CT scans can increase risk of leukemia, thyroid cancer

Radiation from CT scans can increase risk of leukemia, thyroid cancer

Simple blood test can better identify patients at risk of relapse for B-cell lymphoma

Simple blood test can better identify patients at risk of relapse for B-cell lymphoma

Scientists use CAR-T cells to reverse cardiac fibrosis

Scientists use CAR-T cells to reverse cardiac fibrosis

Cancer survivors could be at greater risk of cardiovascular diseases

Cancer survivors could be at greater risk of cardiovascular diseases

People who have a parent, sibling, or child with blood cancer have higher risk of disease

People who have a parent, sibling, or child with blood cancer have higher risk of disease

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

CAR-T cells used to target glioblastoma

CAR-T cells used to target glioblastoma

Why it’s so hard to predict how much funding 9/11 first responders need

Why it’s so hard to predict how much funding 9/11 first responders need

Researchers develop new compound to block therapeutic target in aggressive blood cancer

Researchers develop new compound to block therapeutic target in aggressive blood cancer

Mathematical model helps quantify metastatic cell behavior

Mathematical model helps quantify metastatic cell behavior

AI-enabled device detects if targeted chemotherapy is working

AI-enabled device detects if targeted chemotherapy is working

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Surgery can be beneficial for one type of primary central nervous system lymphoma

Surgery can be beneficial for one type of primary central nervous system lymphoma

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear